NYSE:BCR C.R. Bard (BCR) Stock Price, News & Analysis Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$331.24▼$331.2450-Day Range N/A52-Week Range$222.42▼$337.73VolumeN/AAverage Volume679,456 shsMarket CapitalizationN/AP/E Ratio21.91Dividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get C.R. Bard alerts: Email Address Ad Behind the MarketsJ.P. Morgan’s DIRE WarningWhen the largest bank in the U.S. says a crisis is coming - you NEED to listen. The Wall Street Journal warns, "America's bonds are getting harder to sell."Click here to see why Wall Street is in PANIC mode >>> About C.R. Bard Stock (NYSE:BCR)C. R. Bard, Inc. (Bard) is engaged in designing, manufacturing, packaging, distribution and sale of medical, surgical, diagnostic and patient care devices. The Company operates through the manufacture and sale of medical devices segment. It sells a range of products to hospitals, individual healthcare professionals, extended care facilities and alternate site facilities on a global basis. Its vascular products cover a range of minimally invasive devices for the treatment of peripheral vascular disease and end-stage renal disease. Its urology products include basic urology drainage products, fecal and urinary continence products, urological specialty products and Targeted Temperature Management products. Its oncology products cover a range of devices used in the treatment and management of various cancers, and other diseases and disorders. Its surgical specialty products include implanted patches and fixation devices for hernia and soft tissue repairs.Read More Ad Behind the MarketsJ.P. Morgan’s DIRE WarningWhen the largest bank in the U.S. says a crisis is coming - you NEED to listen. The Wall Street Journal warns, "America's bonds are getting harder to sell."Click here to see why Wall Street is in PANIC mode >>> BCR Stock News HeadlinesJuly 25 at 8:11 AM | msn.comDnD 5e: Every Bard College, RankedMay 29, 2024 | msn.comBard College grad killed by speeding car in Red Hook just hours after getting degree, officials sayJuly 27, 2024 | Crypto Swap Profits (Ad)625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.May 8, 2024 | msn.comBard College library to double in capacity with new expansionApril 30, 2024 | msn.comBard College professor awarded research grant for more than $375kApril 13, 2024 | sports.yahoo.comRockies relief pitcher Daniel Bard needs elbow surgery, will miss rest of seasonApril 13, 2024 | msn.comDaniel Bard Won't Return In 2024April 12, 2024 | msn.comRockies reliever Daniel Bard to undergo season-ending flexor tendon surgeryJuly 27, 2024 | Crypto Swap Profits (Ad)625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.April 12, 2024 | msn.comRockies RHP Daniel Bard to have season-ending elbow surgeryApril 12, 2024 | msn.comRockies RHP Daniel Bard needs elbow surgery, will miss rest of seasonApril 10, 2024 | msn.comDealer Gavin Brown Donates His Archive to Bard College's Curatorial Studies ProgramApril 10, 2024 | msn.comBard Prison Initiative gets $4.5M in federal fundingApril 2, 2024 | msn.comInside a completely free program at Bard MicrocollegeMarch 29, 2024 | msn.comDaniel Bard Begins Season On Injured ListFebruary 20, 2024 | msn.comWhat is Google Bard? Everything you need to know about the ChatGPT rivalFebruary 14, 2024 | msn.comDaniel Bard will be sidelined for five to seven weeks after suffering a tear in his meniscus.February 13, 2024 | msn.comRockies reliever Daniel Bard will have surgery to repair a torn meniscus in left kneeSee More Headlines Receive BCR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for C.R. Bard and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings10/25/2017Today7/26/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorN/A Industry N/A Sub-IndustryHealth Care Equipment Current SymbolNYSE:BCR CUSIP06738310 CIK9892 Webwww.crbard.com Phone+1-908-2778000FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E Ratio21.91 Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 7 Energy Stocks to Buy and Hold ForeverDo you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.Get This Free Report Key ExecutivesTimothy M. Ring (Age 59)Chairman of the Board, Chief Executive Officer John H. Weiland (Age 61)President, Vice Chairman of the Board, Chief Operating Officer James C. Beasley (Age 53)Group President Timothy P. Collins (Age 56)Group President John P. Groetelaars (Age 50)Group President Christopher S. Holland (Age 50)Chief Financial Officer, Senior Vice President Samrat S. Khichi (Age 49)Senior Vice President, General Counsel, Secretary John A. DeFord Ph.D. (Age 55)Senior Vice President - Science, Technology and Clinical Affairs Frank Lupisella Jr. (Age 56)Vice President, Controller Betty D. Larson (Age 41)Vice President - Human Resources More ExecutivesKey CompetitorsAbbott LaboratoriesNYSE:ABTIntuitive SurgicalNASDAQ:ISRGStrykerNYSE:SYKBoston ScientificNYSE:BSXMedtronicNYSE:MDTView All Competitors BCR Stock Analysis - Frequently Asked Questions How were C.R. Bard's earnings last quarter? C.R. Bard Inc (NYSE:BCR) released its earnings results on Wednesday, October, 25th. The medical instruments supplier reported $3.02 earnings per share for the quarter, topping analysts' consensus estimates of $2.96 by $0.06. The firm's revenue was up 5.1% on a year-over-year basis. What other stocks do shareholders of C.R. Bard own? Based on aggregate information from My MarketBeat watchlists, some other companies that C.R. Bard investors own include Abbott Laboratories (ABT), Becton, Dickinson and Company (BDX), Medtronic (MDT), Intuitive Surgical (ISRG), Johnson & Johnson (JNJ), AbbVie (ABBV) and Baxter International (BAX). This page (NYSE:BCR) was last updated on 7/27/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredNext opportunity for crypto millionsThe Bitcoin halving is the #1 creator of "crypto millionaires". That's because historically, every halving has...Crypto 101 Media | Sponsoredtop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligen...Traders Agency | SponsoredThe #1 Crypto for 2024 (3 Cent Coin)Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredAlex's "Next Magnificent Seven" StocksToday Alex Green is releasing his new breakdown of AI's "Next Magnificent Seven." So please make some time ...The Oxford Club | SponsoredNEW AI developed by trader who won 1,129% (in 2 days)Earlier this year one legendary trader captured a 1,129% win (in just 2 days) ... LIVE in front of thousands o...Monument Traders Alliance | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding C.R. Bard Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share C.R. Bard With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.